{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:21:00Z","timestamp":1791091260787,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Association pour le d\u00e9veloppement de la cardiologie"},{"name":"Medtronic, Boston Scientific Corporation"},{"name":"Abbott, Stago and Cordis Corporation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.acvd.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T13:15:10Z","timestamp":1398777310000},"page":"225-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY)"],"prefix":"10.1016","volume":"107","author":[{"given":"Gr\u00e9goire","family":"Rang\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komlavi","family":"Yayehd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Belle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Thuaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cazaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Barbou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"K\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chassaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Teiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Berthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pascale","family":"Decomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Delarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"De Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2014.03.004_bib0005","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.acvd.2014.03.004_bib0010","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.hco.0000409965.20588.c5","article-title":"Responsiveness to P2Y12 receptor inhibitors","volume":"26","author":"Esposito","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-9560-7-4","article-title":"Comparison of VerifyNow-P2Y12 test and flow cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?","volume":"7","author":"Godino","year":"2009","journal-title":"Thromb J"},{"key":"10.1016\/j.acvd.2014.03.004_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.2011.03955.x","article-title":"Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations","volume":"72","author":"Sambu","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ajh.22112","article-title":"Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods","volume":"86","author":"Smock","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jcla.21515","article-title":"A comparison of INNOVANCE(R) PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention","volume":"26","author":"Jang","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.acvd.2014.03.004_bib0035","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.03.004_bib0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10557-008-6121-z","article-title":"Tailoring treatment with tirofiban in patients showing resistance to aspirin and\/or resistance to clopidogrel (3T\/2R). Rationale for the study and protocol design","volume":"22","author":"Valgimigli","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.acvd.2014.03.004_bib0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1538-7836.2009.03733.x","article-title":"Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel","volume":"8","author":"Bouman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2014.03.004_bib0050","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.03.004_bib0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.03.004_bib0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2014.03.004_bib0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2014.03.004_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1160\/TH08-09-0577","article-title":"Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation","volume":"101","author":"Gremmel","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2014.03.004_bib0075","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/eurheartj\/ehn419","article-title":"Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients","volume":"29","author":"Lordkipanidze","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.03.004_bib0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2014.03.004_bib0085","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2010.03.103","volume":"56","author":"Campo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.03.004_bib0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","volume":"52","author":"Patti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0100","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.03.004_bib0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0110","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.03.004_bib0120","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2014.03.004_bib0125","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0130","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.2012.17312","article-title":"Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy","volume":"308","author":"Gurbel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2014.03.004_bib0135","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.108.842757","article-title":"Early stent thrombosis: past, present, and future","volume":"119","author":"Cook","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.03.004_bib0140","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2014.03.004_bib0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2014.03.004_bib0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4244\/51","article-title":"Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?","volume":"5","author":"Cuisset","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2014.03.004_bib0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2008.08.023","article-title":"Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials","volume":"157","author":"Jolly","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2014.03.004_bib0160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.03.004_bib0165","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jacc.2010.12.047","article-title":"Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome","volume":"57","author":"Campo","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:41:56Z","timestamp":1761745316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213614000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1875213614000540"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2014.03.004","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY)","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}